London Daily

Focus on the big picture.
Thursday, Oct 09, 2025

UK biotech hails milestone in hunt for jab to combat  peanut allergies

UK biotech hails milestone in hunt for jab to combat peanut allergies

ABRITISH biotech spun out from SmithKline Beecham in the 1990s is on the brink of a breakthrough in the hunt for the “holy grail” of allergy research - a vaccine for peanut allergy sufferers.

AIM-listed Allergy Therapeutics, based in Worthing, is seeking permission with the US Food and Drug Administration regulator to begin human trials of its short-course jab next year following the publication of results from tests run in collaboration with London’s Imperial College.

The treatment uses a plant-based Cucumber Mosaic Virus engineered to display the key allergen which triggers what can be a potentially life-threatening anaphylactic over-reaction in sufferers.

These virus-like particles (VLPs) train the patient’s immune system to produce protective antibodies against the allergen, in the same way traditional vaccinations protect against invading viruses, which dampen down the response.

Allergy Therapeutics


Results from the Imperial study showed a 24-fold reduction in the activation of infection-fighting white blood cells (basophils) and histamine release after blood samples from allergy patients were challenged with the vaccine.

A short-course treatment of shots would pave the way for a major shift in how one of the most common types of food allergies - whose symptoms can range from mild to severe and life-threatening - is managed.

Around 2% of children in the UK are affected by the condition, of whom only around a fifth outgrow it by the time they reach school age.

The prevalence of peanut allergy doubled between 2005 and 2015 and it is the most common cause of severe and fatal food-induced anaphylactic reactions in the US.

Allergy Therapeutics believes successful human trials will open up opportunities to enter the $8 billion worldwide food allergy market.

Early research is also underway to establish its potential application in oncology and immune conditions such as asthma and psoriasis.

The immunotherapy specialist was formed in 1999, spun out of GSK’s predecessor, and last year recorded sales of £78 million for its portfolio of therapies for mostly pollen-related allergies.

Manuel Llobet, CEO of Allergy Therapeutics, said: “We are pleased to have reached this important milestone in the development of our ground-breaking and disruptive vaccine candidate, VLP Peanut.

“Through our collaboration with Imperial College London and the dedication of our clinical and R&D teams at Allergy Therapeutics, we are another step closer to offering a potentially transformative treatment option for one of the most dangerous allergies.

“I am proud of the work we do in helping to transform patients’ lives and look forward to our upcoming Investigational New Drug submission at the end of this year and expected initiation of our Phase I trial in 2022.”

Shares in Allergy Therapeutics were up 5.59% at 28.35p today.

Newsletter

Related Articles

0:00
0:00
Close
France: Less Than a Month After His Appointment, the New French Prime Minister Resigns
Hungarian Prime Minister Viktor Orbán stated that Hungary will not adopt the euro because the European Union is falling apart.
Sarah Mullally Becomes First Woman Appointed Archbishop of Canterbury
Mayor in western Germany in intensive care after stabbing
Australian government pays Deloitte nearly half a million dollars for a report built on fabricated quotes, fake citations, and AI-generated nonsense.
US Prosecutors Gained Legal Approval to Hack Telegram Servers
Macron Faces Intensifying Pressure to Resign or Trigger New Elections Amid France’s Political Turmoil
Standard Chartered Names Roberto Hoornweg as Sole Head of Corporate & Investment Banking
UK Asylum Housing Firm Faces Backlash Over £187 Million Profits and Poor Living Conditions
UK Police Crack Major Gang in Smuggling of up to 40,000 Stolen Phones to China
BYD’s UK Sales Soar Nearly Nine-Fold, Making Britain Its Biggest Market Outside China
Trump Proposes Farm Bailout from Tariff Revenues Amid Backlash from Other Industries
FIFA Accuses Malaysia of Forging Citizenship Documents, Suspends Seven Footballers
Latvia to Bar Tourist and Occasional Buses to Russia and Belarus Until 2026
A Dollar Coin Featuring Trump’s Portrait Expected to Be Issued Next Year
Australia Orders X to Block Murder Videos, Citing Online Safety and Public Exposure
Three Scientists Awarded Nobel Prize in Medicine for Discovery of Immune Self-Tolerance Mechanism
OpenAI and AMD Forge Landmark AI-Chip Alliance with Equity Option
Munich Airport Reopens After Second Drone Shutdown
France Names New Government Amid Political Crisis
Trump Stands Firm in Shutdown Showdown and Declares War on Drug Cartels — Turning Crisis into Opportunity
Surge of U.S. Billionaires Transforms London’s Peninsula Apartments into Ultra-Luxury Stronghold
Pro Europe and Anti-War Babiš Poised to Return to Power After Czech Parliamentary Vote
Jeff Bezos Calls AI Surge a ‘Good’ Bubble, Urges Focus on Lasting Innovation
Japan’s Ruling Party Chooses Sanae Takaichi, Clearing Path to First Female Prime Minister
Sean ‘Diddy’ Combs Sentenced to Fifty Months in Prison Following Prostitution Conviction
Taylor Swift’s ‘Showgirl’ Launch Extends Billion-Dollar Empire
Trump Administration Launches “TrumpRx” Plan to Enable Direct Drug Sales at Deep Discounts
Trump Announces Intention to Impose 100 Percent Tariff on Foreign-Made Films
Altman Says GPT-5 Already Outpaces Him, Warns AI Could Automate 40% of Work
Singapore and Hong Kong Vie to Dominate Asia’s Rising Gold Trade
Trump Organization Teams with Saudi Developer on $1 Billion Trump Plaza in Jeddah
Manhattan Sees Surge in Office-to-Housing Conversions, Highest Since 2008
Switzerland and U.S. Issue Joint Assurance Against Currency Manipulation
Electronic Arts to Be Taken Private in Historic $55 Billion Buyout
Thomas Jacob Sanford Named as Suspect in Deadly Michigan Church Shooting and Arson
Russian Research Vessel 'Yantar' Tracked Mapping Europe’s Subsea Cables, Raising Security Alarms
New York Man Arrested After On-Air Confession to 2017 Parents’ Murders
U.S. Defense Chief Orders Sudden Summit of Hundreds of Generals and Admirals
Global Cruise Industry Posts Dramatic Comeback with 34.6 Million Passengers in 2024
Trump Claims FBI Planted 274 Agents at Capitol Riot, Citing Unverified Reports
India: Internet Suspended in Bareilly Amid Communal Clashes Between Muslims and Hindus
Supreme Court Extends Freeze on Nearly $5 Billion in U.S. Foreign Aid at Trump’s Request
Archaeologists Recover Statues and Temples from 2,000-Year-Old Sunken City off Alexandria
China Deploys 2,000 Workers to Spain to Build Major EV Battery Factory, Raising European Dependence
Speed Takes Over: How Drive-Through Coffee Chains Are Rewriting U.S. Coffee Culture
U.S. Demands Brussels Scrutinize Digital Rules to Prevent Bias Against American Tech
Ringo Starr Champions Enduring Beatles Legacy While Debuting Las Vegas Art Show
Private Equity’s Fundraising Surge Triggers Concern of European Market Shake-Out
Colombian President Petro Vows to Mobilize Volunteers for Gaza and Joins List of Fighters
×